For cancer patients on immunotherapy, harmful gut bacteria might matter more than helpful ones
Melanoma patients receiving therapy that helps their immune system kill cancer cells respond to treatment differently depending on the types of microbes in their gut, and new research suggests the microorganisms hindering therapy have more influence than the beneficial ones.
Materials provided by Oregon State University. Original written by Steve Lundeberg. Note: Content may be edited for style and length.
Source link aaaaa